- Report
- June 2019
- 15 Pages
Global
- Report
- July 2021
- 120 Pages
Global
From €3965EUR$4,100USD£3,398GBP
- Report
- February 2024
- 107 Pages
Global
From €3500EUR$3,877USD£3,105GBP
- Report
- February 2024
- 109 Pages
Global
From €3500EUR$3,877USD£3,105GBP
- Report
- February 2024
- 114 Pages
Global
From €3500EUR$3,877USD£3,105GBP
- Report
- January 2024
- 132 Pages
Global
From €919EUR$950USD£787GBP
- Report
- November 2021
- 1032 Pages
Global
From €4835EUR$5,000USD£4,144GBP
- Report
- May 2019
- 255 Pages
Global
From €5193EUR$5,370USD£4,451GBP
- Book
- April 2020
- 608 Pages
- Book
- March 2010
- 784 Pages
Biomarker Analytics is a rapidly growing field within the larger field of Biomarkers. It involves the use of advanced analytics to identify, measure, and interpret biological markers in order to gain insights into the health of individuals and populations. This includes the use of data from clinical trials, medical records, and other sources to identify biomarkers that can be used to diagnose and treat diseases. Biomarker Analytics also involves the development of predictive models to identify individuals at risk for certain diseases and to monitor the progression of diseases.
The Biomarker Analytics market is driven by the increasing demand for personalized medicine and the need for more accurate and cost-effective diagnostics. Companies in this market include Illumina, Qiagen, Thermo Fisher Scientific, Roche, and Agilent Technologies. Show Less Read more